US Patent

US12295953 — Oral gliptin compositions and method for preparation thereof

Formulation · Assigned to Pharma Data Research And Development Single Member SA · Expires 2040-10-23 · 14y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects liquid oral gliptin compositions with improved taste and stability, and methods for manufacturing them.

USPTO Abstract

Described herein are liquid oral gliptin compositions. The liquid oral gliptin compositions may comprise a gliptin or a pharmaceutically acceptable salt thereof, an artificial non-sugar alcohol sweetening agent, and liquid oral gliptin compositions may have a sugar alcohol content of less 25 w/v %. The liquid oral gliptin compositions described herein have improved taste and stability. Further provided herein are methods of manufacturing liquid oral gliptin compositions.

Drugs covered by this patent

Patent Metadata

Patent number
US12295953
Jurisdiction
US
Classification
Formulation
Expires
2040-10-23
Drug substance claim
No
Drug product claim
Yes
Assignee
Pharma Data Research And Development Single Member SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.